STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Stat News • 2/5/2026 – 2/6/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
2
4
2
1
2026-02-052026-02-11
Lindy Score Breakdown (V4.2)
12d
Age
3
Sources
from cluster
268
Hours Since Seen
Final Score1/100
CategoryAntiLindy
StatusArchived
Recency Multiplier2% (0.5^268/48)
Hero EligibleNo
Story Timeline
- 2026-02-05STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill (current)
- 2026-02-06
- 2026-02-07
- 2026-02-09
- 2026-02-11
Score BreakdownRisk 35
Source Reputation: Low-trust source (4/20 pts)
Consensus: Emerging consensus: 3 sources
Age: 11 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 10 sources
STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?
Stat News • 6 days ago
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News • 1 week ago
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Stat News • 1 week ago
STAT+: Hims & Hers will stop selling compounded version of Novo’s obesity pill
Stat News • 1 week ago
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Financial Times • 1 week ago
HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy - statnews.com
Stat News • 1 week ago
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
Stat News • 1 week ago
US health company launches weight-loss pill that Novo Nordisk calls an 'untested knockoff'
Euronews • 1 week ago
Breaking Similar stories
STAT+: Breakup between Brigham and Dana-Farber is getting messier fast
Stat News • 1 day ago
STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials
Stat News • Today
STAT+: As China’s drug industry races ahead, its GLP-1 race is accelerating too
Stat News • Today
STAT+: In a financial pinch, major health insurers are turning to AI for help
Stat News • Today
STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods
Stat News • 1 day ago
STAT+: Exit of CDC’s acting director highlights agency’s lack of leader
Stat News • 1 day ago
STAT+: Medicare Advantage growth dwindles for a second straight year
Stat News • Today
Opinion: AMA CEO: Deepfake doctors are a threat to public health
Stat News • Today
Opinion: When IV opioids are in short supply at the hospital, who gets pain relief?
Stat News • Today
Opinion: How public health saved the CDC Injury Center
Stat News • 1 day ago